🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

18,54 USD

Máx. histórico

178,74

2142 días

Split 1:6 del 12/07/2012

Caída desde máximo

-89,63%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,20%

Cierre anterior

18,32

Rango de hoy

18,29 – 18,81

Volumen hoy

1.397.929

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,44%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 7 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
16/06/1998 35,25 35,63 34,13 35,63 +4,40% 4,26% 5.383
15/06/1998 36,00 36,75 33,75 34,13 -7,14% 8,33% 10.717
12/06/1998 36,75 37,13 33,94 36,75 -2,00% 8,67% 14.917
11/06/1998 39,38 39,38 37,50 37,50 -4,76% 4,76% 7.000
10/06/1998 39,75 41,25 39,00 39,38 -0,94% 5,66% 6.650
09/06/1998 40,50 41,25 39,75 39,75 +0,00% 3,70% 10.350
08/06/1998 39,00 40,50 37,50 39,75 +3,92% 7,69% 8.000
05/06/1998 40,31 40,50 37,88 38,25 -5,12% 6,51% 14.067
04/06/1998 39,75 41,25 39,00 40,31 -0,46% 5,66% 9.517
03/06/1998 43,13 43,50 40,50 40,50 +0,00% 6,96% 16.933
02/06/1998 41,25 41,63 40,50 40,50 -0,92% 2,73% 2.633
01/06/1998 41,25 42,00 40,88 40,88 -2,68% 2,73% 2.517
29/05/1998 40,88 42,00 40,13 42,00 +3,70% 4,59% 11.167
28/05/1998 40,13 41,25 40,13 40,50 -0,92% 2,80% 4.883
27/05/1998 41,25 41,25 39,38 40,88 +0,00% 4,55% 7.233
26/05/1998 43,50 43,50 40,50 40,88 -5,22% 6,90% 6.583
22/05/1998 42,00 43,50 42,00 43,13 +6,48% 3,57% 5.933
21/05/1998 43,50 43,50 40,50 40,50 -5,26% 6,90% 5.233
20/05/1998 44,25 45,00 42,38 42,75 -3,39% 5,93% 7.117
19/05/1998 40,88 45,00 40,13 44,25 +8,26% 11,93% 27.400
18/05/1998 39,75 41,25 39,38 40,88 +3,81% 4,72% 18.817
15/05/1998 40,13 40,50 39,38 39,38 -1,87% 2,80% 5.517
14/05/1998 40,50 41,25 40,13 40,13 +0,00% 2,78% 8.500
13/05/1998 39,38 40,50 39,38 40,13 +0,94% 2,86% 15.850
12/05/1998 39,00 40,13 39,00 39,75 +0,95% 2,88% 10.133
11/05/1998 41,25 41,25 39,38 39,38 -4,55% 4,55% 2.200
08/05/1998 39,75 41,25 39,38 41,25 +2,80% 4,72% 3.183
07/05/1998 41,25 42,00 39,38 40,13 -2,73% 6,36% 9.817
06/05/1998 42,00 42,75 40,50 41,25 -0,90% 5,36% 3.017
05/05/1998 42,75 42,75 41,25 41,63 +2,78% 3,51% 700